Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: a cluster randomised controlled trial
F Kaasenbrood, M Hollander, SHM de Bruijn… - British Journal of …, 2020 - bjgp.org
Background Atrial fibrillation (AF) increases the risk of stroke, heart failure, and all-cause
mortality. AF may be asymptomatic and therefore remain undiagnosed. Devices such as single-…
mortality. AF may be asymptomatic and therefore remain undiagnosed. Devices such as single-…
Application of the ugi multicomponent reaction in the synthesis of reactivators of nerve agent inhibited acetylcholinesterase
…, DPW Alkema, T Wille, HM de Bruijn - Journal of Medicinal …, 2017 - ACS Publications
Recently, a new class of reactivators of chemical warfare agent inhibited acetylcholinesterase
(AChE) with promising in vitro potential was developed by the covalent linkage of an …
(AChE) with promising in vitro potential was developed by the covalent linkage of an …
[PDF][PDF] A comprehensive pan-cancer molecular study of gynecologic and breast cancers
…, J Armenia, D Chakravarty, WK Chatila, I de Bruijn… - Cancer cell, 2018 - cell.com
We analyzed molecular data on 2,579 tumors from The Cancer Genome Atlas (TCGA) of
four gynecological types plus breast. Our aims were to identify shared and unique molecular …
four gynecological types plus breast. Our aims were to identify shared and unique molecular …
[PDF][PDF] Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
We conducted comprehensive integrative molecular analyses of the complete set of tumors
in The Cancer Genome Atlas (TCGA), consisting of approximately 10,000 specimens and …
in The Cancer Genome Atlas (TCGA), consisting of approximately 10,000 specimens and …
[PDF][PDF] Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas
…, J Armenia, D Chakravarty, WK Chatila, I de Bruijn… - Cell reports, 2018 - cell.com
DNA damage repair (DDR) pathways modulate cancer risk, progression, and therapeutic
response. We systematically analyzed somatic alterations to provide a comprehensive view of …
response. We systematically analyzed somatic alterations to provide a comprehensive view of …
Comparative Sequence Analysis of the Symbiosis Island of Mesorhizobium loti Strain R7A
…, JE Weaver, RJ Webby, FJ De Bruijn… - Journal of …, 2002 - Am Soc Microbiol
The Mesorhizobium loti strain R7A symbiosis island is a 502-kb chromosomally integrated
element which transfers to nonsymbiotic mesorhizobia in the environment, converting them to …
element which transfers to nonsymbiotic mesorhizobia in the environment, converting them to …
[PDF][PDF] The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma
…, J Armenia, D Chakravarty, WK Chatila, I de Bruijn… - Cell reports, 2018 - cell.com
Renal cell carcinoma (RCC) is not a single disease, but several histologically defined cancers
with different genetic drivers, clinical courses, and therapeutic responses. The current …
with different genetic drivers, clinical courses, and therapeutic responses. The current …
[PDF][PDF] Genomic and functional approaches to understanding cancer aneuploidy
…, J Armenia, D Chakravarty, WK Chatila, I de Bruijn… - Cancer cell, 2018 - cell.com
Aneuploidy, whole chromosome or chromosome arm imbalance, is a near-universal
characteristic of human cancers. In 10,522 cancer genomes from The Cancer Genome Atlas, …
characteristic of human cancers. In 10,522 cancer genomes from The Cancer Genome Atlas, …
[PDF][PDF] Uncovering Zimbabwe's debt
…, O Brynildsen, P Bond, K Rehbein, K de Bruijn… - Jubilee Debt …, 2011 - erlassjahr.de
Eurodad works to push for policies that support pro-poor and democratically-defined sustainable
development strategies. We support the empowerment of Southern people to chart their …
development strategies. We support the empowerment of Southern people to chart their …
[PDF][PDF] Pathogenic germline variants in 10,389 adult cancers
We conducted the largest investigation of predisposition variants in cancer to date, discovering
853 pathogenic or likely pathogenic variants in 8% of 10,389 cases from 33 cancer types. …
853 pathogenic or likely pathogenic variants in 8% of 10,389 cases from 33 cancer types. …